全文获取类型
收费全文 | 2348138篇 |
免费 | 171523篇 |
国内免费 | 5790篇 |
专业分类
耳鼻咽喉 | 32191篇 |
儿科学 | 77625篇 |
妇产科学 | 66933篇 |
基础医学 | 344122篇 |
口腔科学 | 65391篇 |
临床医学 | 216107篇 |
内科学 | 452678篇 |
皮肤病学 | 47983篇 |
神经病学 | 189847篇 |
特种医学 | 87855篇 |
外国民族医学 | 696篇 |
外科学 | 342439篇 |
综合类 | 51113篇 |
现状与发展 | 2篇 |
一般理论 | 731篇 |
预防医学 | 188879篇 |
眼科学 | 53245篇 |
药学 | 176200篇 |
7篇 | |
中国医学 | 5045篇 |
肿瘤学 | 126362篇 |
出版年
2018年 | 25269篇 |
2017年 | 19016篇 |
2016年 | 21038篇 |
2015年 | 24107篇 |
2014年 | 33256篇 |
2013年 | 51338篇 |
2012年 | 70428篇 |
2011年 | 75171篇 |
2010年 | 44041篇 |
2009年 | 40928篇 |
2008年 | 70428篇 |
2007年 | 75167篇 |
2006年 | 75955篇 |
2005年 | 73915篇 |
2004年 | 70732篇 |
2003年 | 67863篇 |
2002年 | 66332篇 |
2001年 | 103926篇 |
2000年 | 106576篇 |
1999年 | 90161篇 |
1998年 | 26020篇 |
1997年 | 23451篇 |
1996年 | 23395篇 |
1995年 | 22141篇 |
1994年 | 20862篇 |
1993年 | 19455篇 |
1992年 | 72476篇 |
1991年 | 71394篇 |
1990年 | 69727篇 |
1989年 | 67089篇 |
1988年 | 62308篇 |
1987年 | 60850篇 |
1986年 | 58166篇 |
1985年 | 55648篇 |
1984年 | 41800篇 |
1983年 | 35949篇 |
1982年 | 21700篇 |
1981年 | 19241篇 |
1979年 | 39039篇 |
1978年 | 27666篇 |
1977年 | 23331篇 |
1976年 | 22484篇 |
1975年 | 23868篇 |
1974年 | 28570篇 |
1973年 | 27861篇 |
1972年 | 26158篇 |
1971年 | 24281篇 |
1970年 | 22606篇 |
1969年 | 21287篇 |
1968年 | 20115篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
21.
Timothy J. Cordingley Mark A.G. Wilson Kathryn M. Weston 《Health & social care in the community》2022,30(1):353-359
Vaccination is a vital health care initiative to prevent individual and population infection. To increase vaccination rates the federal government implemented the ‘No Jab, No Pay’ policy, where eligibility for several government benefits required children to be fully vaccinated by removing ‘conscientious objections’ and expanding the age range of children whose families receive benefits. This study assesses the impact of this policy at a local area within a single medical practice community in NSW, Australia. A retrospective clinical audit was performed between 2012 and 2017 on a single general practice's vaccination records for children ≤19 years. Catch-up vaccinations were assessed based on age at vaccination. Incidence of catch-up vaccinations was assessed for each of four years before and two years after the implementation of the ‘No Jab, No Pay’ policy in January 2016, along with the age of children and vaccination(s) given. Catch-up vaccinations were assessed temporally either side of implementation of ‘No Jab, No Pay’. Comparing the average annual vaccination catch-up incidence rate of 6.2% pre-implementation (2012–2015), there was an increase to 9.2% in 2016 (p < .001) and 7.8% in 2017 (p = .027). Secondary outcome measurement of catch-up vaccination incidence rates before (2012–2015) and after (2016–2017) ‘No Jab, No Pay’ implementation showed statistically significant increases for children aged 8–11 years (3.2%–5.6%, p = .038), 12–15 years (7.5%–14.7%, p < .001) and 16–19 years (3.3%–10.2%, p < .001) along with a statistically significant reduction in children aged 1–3 years (11.4%–6.2%, p = .015). Also, catch-up rates for DTPa significantly increased after program implementation. This study demonstrates that the Australian federal government vaccination policy ‘No Jab, No Pay’ was coincident with an increase in catch-up vaccinations within a rural NSW community served by one medical practice, especially for older children. 相似文献
22.
23.
24.
Marike Gabrielson Mattias Hammarström Magnus Bäcklund Jenny Bergqvist Kristina Lång Ann H Rosendahl Signe Borgquist Roxanna Hellgren Kamila Czene Per Hall 《International journal of cancer. Journal international du cancer》2023,152(11):2362-2372
Tamoxifen prevents recurrence of breast cancer and is suggested for preventive risk-reducing therapy. Tamoxifen reduces mammographic density, a proxy for therapy response, but little is known about its effects in remodelling normal breast tissue. Our study, a substudy within the double-blinded dose-determination trial KARISMA, investigated tamoxifen-specific changes in breast tissue composition and histological markers in healthy women. We included 83 healthy women randomised to 6 months daily intake of 20, 10, 5, 2.5, 1 mg of tamoxifen or placebo. The groups were combined to “no dose” (0-1 mg), “low-dose” (2.5-5 mg) or “high-dose” (10-20 mg) of tamoxifen. Ultrasound-guided biopsies were collected before and after tamoxifen exposure. In each biopsy, epithelial, stromal and adipose tissues was quantified, and expression of epithelial and stromal Ki67, oestrogen receptor (ER) and progesterone receptor (PR) analysed. Mammographic density using STRATUS was measured at baseline and end-of-tamoxifen-exposure. We found that different doses of tamoxifen reduced mammographic density and glandular-epithelial area in premenopausal women and associated with reduced epithelium and increased adipose tissue. High-dose tamoxifen also decreased epithelial ER and PR expressions in premenopausal women. Premenopausal women with the greatest reduction in proliferation also had the greatest epithelial reduction. In postmenopausal women, high-dose tamoxifen decreased the epithelial area with no measurable density decrease. Tamoxifen at both low and high doses influences breast tissue composition and expression of histological markers in the normal breast. Our findings connect epithelial proliferation with tissue remodelling in premenopausal women and provide novel insights to understanding biological mechanisms of primary prevention with tamoxifen. 相似文献
25.
卫逸涛肖惠敏谢银环孙丽军 《中华健康管理学杂志》2022,(8):547-552
目的了解老年人生命晚期获知疾病相关信息意向及影响因素。方法2016年10月至2017年6月,采用生命晚期疾病信息意向问卷,利用方便抽样法对福州市中心城区7所养老机构及15个社区的414例年龄≥60岁的老年人进行横断面调查,采用单因素分析、多元线性回归与有序多分类logistic回归分析老年人对疾病相关信息的需求水平、获知程度意向及其影响因素。结果414例老年人疾病相关信息需求得分为(17.1±4.9)分;48.8%(202/414)希望详尽知晓,30.7%(127/414)希望选择性了解,20.5%(85/414)不想知道任何信息;多元线性回归分析显示,年龄、文化程度、是否接受/见过其他生命维持治疗(LSTs)是影响老年人疾病相关信息需求水平的主要因素(标准化回归系数分别为-0.141、0.116、0.115,均P<0.05);有序多分类logistic分析显示,年龄(以60~69岁为参照,70~79岁:OR=0.544,95%CI:0.310~0.957;80~89岁:OR=0.526,95%CI:0.289~0.956)、文化程度(以小学及以下为参照,大专及以上:OR=2.166,95%CI:1.093~4.290)、主要生活费来源(以其他补贴为参照,家人支持:OR=7.303,95%CI:1.157~46.108;退休金:OR=9.288,95%CI:1.502~57.415;公积金/储蓄:OR=15.676,95%CI:2.122~115.793)、是否接受/见过其他LSTs(以是为参照,OR=1.985,95%CI:1.150~3.425)是影响老年人疾病相关信息获知程度意向的主要因素。结论老年人生命晚期获知疾病相关信息的意向程度较高,年龄、文化程度、主要生活费来源、是否接受/见过其他生命维持治疗等是其主要影响因素。 相似文献
26.
27.
28.
29.